Prothena Corp. Plc (PRTA)

10.53 -0.65 (-5.81%) USD  |  NASDAQ  |  May 07, 16:00
10.53 0.00 (0.00%) After-Hours: 20:00
More

Prothena Research and Development Expense (Annual) : 134.85M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for PRTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Novo Nordisk A/S 6.838B
Jazz Pharmaceuticals Plc 782.74M
Amarin Corp. Plc 16.82M
Iterum Therapeutics Plc 10.17M
GH Research Plc 38.73M